Caplin Point gets Colombia's INVIMA approval for sterile injectables

13 May 2019 Evaluate

Caplin Point Laboratories has received Colombia's INVIMA approval for its small volume sterile injectable division at Puducherry. The site inspection of Unit-1 was completed on May 10 and found compliant as per INVIMA's norms of Good Manufacturing Practices (GMP) and Good Laboratory Practices (GLP). The facility is capable of manufacturing Liquid injectables in Vials, Ampoules, Lyophilized Vials and Pre-Filled Syringes, amongst other dosage forms.

Caplin Point Laboratories is engaged mainly in manufacturing a wide range of Ointments, Creams and other External application preparations in addition to the regular segments of pharmaceutical formulations.

Caplin Point Lab Share Price

1831.00 26.15 (1.45%)
13-Jan-2026 11:41 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1723.20
Dr. Reddys Lab 1201.80
Cipla 1447.00
Zydus Lifesciences 895.40
Lupin 2171.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×